- Report
- February 2024
- 87 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- March 2025
- 50 Pages
Global
From €2519EUR$2,650USD£2,116GBP
- Report
- March 2025
- 50 Pages
Global
From €2519EUR$2,650USD£2,116GBP
- Report
- March 2025
- 50 Pages
Global
From €2519EUR$2,650USD£2,116GBP
- Report
- March 2025
- 50 Pages
Global
From €2519EUR$2,650USD£2,116GBP
Hypoxanthine is a drug used to treat gastrointestinal disorders. It is a purine analogue that works by inhibiting the enzyme xanthine oxidase, which is responsible for the breakdown of purines. This leads to an increase in the levels of uric acid in the body, which helps to reduce inflammation and pain associated with gastrointestinal disorders. Hypoxanthine is available in both oral and injectable forms and is often used in combination with other drugs to treat gastrointestinal disorders.
Hypoxanthine is used to treat a variety of gastrointestinal disorders, including Crohn's disease, ulcerative colitis, and irritable bowel syndrome. It is also used to treat gout, a condition caused by high levels of uric acid in the body. Hypoxanthine is generally well tolerated and has few side effects.
Some companies in the Hypoxanthine market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more